Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Adalimumab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Biogen
Mylan
AbbVie
Boehringer Ingelheim
Sandoz
Amgen
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Adalimumab
Adalimumab Biosimilar
Application:
Adults
Children
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Adalimumab Industry Overview
-
1.1.1 Adalimumab Market Scope and Market Segments
-
1.1.2 Adalimumab Industry Characteristics
-
1.1.3 Global and China Adalimumab Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Adalimumab Production Value and Growth Rate (2017-2028)
-
1.2 Global Adalimumab Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Adalimumab
-
1.2.2 Adalimumab Biosimilar
-
1.3 Global Adalimumab Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Adults
-
1.3.2 Children
-
1.4 Market Analysis by Region
-
1.4.1 North America Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Adalimumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Adalimumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Adalimumab Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Adalimumab Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Adalimumab Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Adalimumab Industry Porter's Five Forces Model Analysis
-
2.2.3 Adalimumab Industry PEST Analysis
-
2.3 Adalimumab Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Adalimumab Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Adalimumab Industry
Chapter 3 Global and China Adalimumab Market, by Manufacturer
-
3.1 Global and China Adalimumab Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Adalimumab Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Adalimumab Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Adalimumab Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Adalimumab Market Top 3 Players
Chapter 4 Global and China Adalimumab Market, by Type (2017-2028)
-
4.1 Adalimumab Market Trend, by Type
-
4.2 Global Adalimumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Adalimumab Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Adalimumab Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Adalimumab Price Trend, by Type (2017-2028)
-
4.3 China Adalimumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Adalimumab Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Adalimumab Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Adalimumab Price Trend, by Type (2017-2028)
Chapter 5 Global and China Adalimumab Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Adalimumab Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Adalimumab Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Adalimumab Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Adalimumab Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Adalimumab Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Adalimumab Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Adalimumab Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Adalimumab Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Adalimumab Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Adalimumab Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Adalimumab Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Adalimumab Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Adalimumab Market Analysis
-
7.1 North America Adalimumab Market, by Type
-
7.2 North America Adalimumab Market, by Application
-
7.3 North America Adalimumab Market Analysis and Forecast, by Country
-
7.3.1 United States Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Adalimumab Market Analysis
-
8.1 Europe Adalimumab Market, by Type
-
8.2 Europe Adalimumab Market, by Application
-
8.3 Europe Adalimumab Market Analysis and Forecast, by Country
-
8.3.1 Germany Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Adalimumab Market Analysis
-
9.1 APAC Adalimumab Market, by Type
-
9.2 APAC Adalimumab Market, by Application
-
9.3 APAC Adalimumab Market Analysis and Forecast, by Country
-
9.3.1 China Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Adalimumab Market Analysis
-
10.1 Latin America, Middle East and Africa Adalimumab Market, by Type
-
10.2 Latin America, Middle East and Africa Adalimumab Market, by Application
-
10.3 Latin America, Middle East and Africa Adalimumab Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Adalimumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Adalimumab Company Profiles
-
11.1 Biogen
-
11.1.1 Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Biogen Adalimumab Product Profiles, Application and Specification
-
11.1.3 Biogen Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Mylan
-
11.2.1 Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Mylan Adalimumab Product Profiles, Application and Specification
-
11.2.3 Mylan Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 AbbVie
-
11.3.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 AbbVie Adalimumab Product Profiles, Application and Specification
-
11.3.3 AbbVie Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Boehringer Ingelheim
-
11.4.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Boehringer Ingelheim Adalimumab Product Profiles, Application and Specification
-
11.4.3 Boehringer Ingelheim Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Sandoz
-
11.5.1 Sandoz Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Sandoz Adalimumab Product Profiles, Application and Specification
-
11.5.3 Sandoz Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Amgen
-
11.6.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Amgen Adalimumab Product Profiles, Application and Specification
-
11.6.3 Amgen Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Adalimumab Industry Investment Prospect and Risk Assessment
-
12.1 Adalimumab Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Adalimumab Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Global Adalimumab Production Value and Growth Rate (2017-2028)
-
Figure China Adalimumab Production Value and Growth Rate (2017-2028)
-
Figure Global Adalimumab Market Size and Growth Rate of Adalimumab (2017-2028)
-
Figure Global Adalimumab Market Size and Growth Rate of Adalimumab Biosimilar (2017-2028)
-
Figure Global Adalimumab Market Size and Growth Rate of Adults (2017-2028)
-
Figure Global Adalimumab Market Size and Growth Rate of Children (2017-2028)
-
Figure North America Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Adalimumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Adalimumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Adalimumab Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Adalimumab Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Adalimumab Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Adalimumab Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Adalimumab Market Share, by Manufacturer in 2021
-
Figure Global and China Adalimumab Market Share, by Manufacturer in 2022
-
Table Global Adalimumab Sales Volume, by Type (2017-2028)
-
Table Global Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure Global Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table Global Adalimumab Sales Value, by Type (2017-2028)
-
Table Global Adalimumab Sales Value Share, by Type (2017-2028)
-
Figure Global Adalimumab Price Trend, by Type (2017-2028)
-
Table China Adalimumab Sales Volume, by Type (2017-2028)
-
Table China Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure China Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table China Adalimumab Sales Value, by Type (2017-2028)
-
Table China Adalimumab Sales Value Share, by Type (2017-2028)
-
Figure China Adalimumab Price Trend, by Type (2017-2028)
-
Table Global Adalimumab Sales Volume, by Application (2017-2028)
-
Table Global Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure Global Adalimumab Sales Volume Share, by Application (2017-2028)
-
Table Global Adalimumab Sales Value, by Application (2017-2028)
-
Table Global Adalimumab Sales Value Share, by Application (2017-2028)
-
Figure Global Adalimumab Sales Value Share, by Application (2017-2028)
-
Table China Adalimumab Sales Volume, by Application (2017-2028)
-
Table China Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure China Adalimumab Sales Volume Share, by Application (2017-2028)
-
Table China Adalimumab Sales Value, by Application (2017-2028)
-
Table China Adalimumab Sales Value Share, by Application (2017-2028)
-
Figure China Adalimumab Sales Value Share, by Application (2017-2028)
-
Figure China Adalimumab Production, Import, Consumption and Export (2017-2022)
-
Figure North America Adalimumab Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Adalimumab Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Adalimumab Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Adalimumab Production, Import, Consumption and Export (2017-2022)
-
Table North America Adalimumab Sales Volume, by Type (2017-2028)
-
Table North America Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure North America Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table North America Adalimumab Sales Volume, by Application (2017-2028)
-
Table North America Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure North America Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure United States Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure United States Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Canada Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Adalimumab Sales Value and Growth Rate (2017-2028)
-
Table Europe Adalimumab Sales Volume, by Type (2017-2028)
-
Table Europe Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure Europe Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table Europe Adalimumab Sales Volume, by Application (2017-2028)
-
Table Europe Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure Europe Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure Germany Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure UK Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure UK Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure France Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure France Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Italy Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Spain Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Poland Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Russia Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Adalimumab Sales Value and Growth Rate (2017-2028)
-
Table APAC Adalimumab Sales Volume, by Type (2017-2028)
-
Table APAC Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure APAC Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table APAC Adalimumab Sales Volume, by Application (2017-2028)
-
Table APAC Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure APAC Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure China Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Japan Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure India Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure India Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Adalimumab Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Adalimumab Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Adalimumab Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Adalimumab Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Adalimumab Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Adalimumab Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Adalimumab Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Adalimumab Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Adalimumab Sales Value and Growth Rate (2017-2028)
-
Table Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biogen Product Profiles, Application and Specification
-
Table Biogen Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mylan Product Profiles, Application and Specification
-
Table Mylan Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AbbVie Product Profiles, Application and Specification
-
Table AbbVie Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim Product Profiles, Application and Specification
-
Table Boehringer Ingelheim Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sandoz Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sandoz Product Profiles, Application and Specification
-
Table Sandoz Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Adalimumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
